BioAesthetics
The next step in breast reconstruction
BioAesthetics is active in the human health space based in United States, founded in 2015.
Profile
BioAesthetics is developing a tissue engineered nipple-areolar complex (NAC) for patients with incomplete or removed NACs due to disease, surgery, or birth defects. BioAesthetics will provide an off-the-shelf-ready, human-derived, acellular NAC graft to plastic and reconstructive surgeons.
BioAesthetics is positioned in human health, a segment that rewards a clear, focused offering.
The business is associated with United States.
The company is listed at the SOSV portfolio company stage of development.
Its team size is recorded as 2-10 employees.
Public records show total funding of about $4.6M.
| Sector | Human Health |
|---|---|
| Country | United States |
| Founded | 2015 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $4,632,850 |
Website: bio-aesthetics.com
Create a free account